文献速递垂体与肾上腺疾病性腺与生殖内分泌

肾上腺功能初现更新:仍是一个谜

Update on Adrenarche-Still a Mystery.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本文综述了过去5年关于肾上腺功能初现及过早肾上腺功能初现(PA)的文献,指出肾上腺功能初现的确切机制仍未解决,PA按当前定义在女孩中患病率可高达9%至23%、男孩中2%至10%,但仅部分儿童可能面临相关不良健康结局,需要新的定义标准及前瞻性长期研究。

要点

  • 肾上腺功能初现的确切分子机制仍未解决,多种调节因子似乎参与其中。
  • 11-氧雄激素通路中的11-酮睾酮是肾上腺功能初现的有前景标志物。
  • 按当前定义,PA患病率女孩9%至23%、男孩2%至10%,仅部分儿童可能有不良结局。

核心结论

  • 需要新的肾上腺功能初现和PA定义标准,以识别有 later disease 风险的儿童并避免对正常变异儿童的过度干预。
  • 需要进一步研究以理解肾上腺功能初现。
  • 应开展前瞻性长期研究,刻画调节出生体型、早期出生后生长、儿童期超重/肥胖、肾上腺功能初现和青春期启动轨迹的产前或早期出生后发育通路,以及导致异常性成熟、生育力和其他不良结局的轨迹。

研究设计与样本

  • 本文为文献综述,检索了过去5年PubMed、ScienceDirect、Web of Science、Embase和Scopus中的原创文章、综述和Meta分析,检索词包括adrenarche、pubarche、DHEAS、steroidogenesis、adrenal和zona reticularis。

主要发现

  • 肾上腺功能初现标志着人类肾上腺发育的时间点,此时皮质开始分泌 increasing amounts 的雄激素,健康儿童在8至9岁时出现,PA则更早。
  • 基础研究增进了对人类肾上腺发育、分区和网状带功能的了解,但导致肾上腺功能初现的确切机制仍未解决,许多调节因子似乎参与其中。
  • 在11-氧雄激素通路中发现了肾上腺功能初现的有前景标志物11-酮睾酮。
  • 按当前定义,PA患病率女孩可高达9%至23%,男孩2%至10%,但仅部分儿童可能面临相关不良健康结局。

关键数值与推荐

  • 按当前定义,PA患病率女孩可高达9%至23%,男孩2%至10%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 肾上腺功能初现的分子调节和意义未知,因此这一青春期前事件仅能被描述性刻画。
  • PA是排除性诊断,长期后果不明确。
  • 导致肾上腺功能初现的确切机制仍未解决。
  • 需要进一步研究以理解肾上腺功能初现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adrenarche marks the timepoint of human adrenal development when the cortex starts secreting androgens in increasing amounts, in healthy children at age 8-9 years, with premature adrenarche (PA) earlier. Because the molecular regulation and significance of adrenarche are unknown, this prepubertal event is characterized descriptively, and PA is a diagnosis by exclusion with unclear long-term consequences. EVIDENCE ACQUISITION: We searched the literature of the past 5 years, including original articles, reviews, and meta-analyses from PubMed, ScienceDirect, Web of Science, Embase, and Scopus, using search terms adrenarche, pubarche, DHEAS, steroidogenesis, adrenal, and zona reticularis. EVIDENCE SYNTHESIS: Numerous studies addressed different topics of adrenarche and PA. Although basic studies on human adrenal development, zonation, and zona reticularis function enhanced our knowledge, the exact mechanism leading to adrenarche remains unsolved. Many regulators seem involved. A promising marker of adrenarche (11-ketotestosterone) was found in the 11-oxy androgen pathway. By current definition, the prevalence of PA can be as high as 9% to 23% in girls and 2% to 10% in boys, but only a subset of these children might face related adverse health outcomes. CONCLUSION: New criteria for defining adrenarche and PA are needed to identify children at risk for later disease and to spare children with a normal variation. Further research is therefore required to understand adrenarche. Prospective, long-term studies should characterize prenatal or early postnatal developmental pathways that modulate trajectories of birth size, early postnatal growth, childhood overweight/obesity, adrenarche and puberty onset, and lead to abnormal sexual maturation, fertility, and other adverse outcomes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Augsburger P, Liimatta J, Flück CE, et al. Update on Adrenarche-Still a Mystery. J Clin Endocrinol Metab. 2024. PMID: 38181424. doi:10.1210/clinem/dgae008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。